Open access

Integrated immunoinformatics and molecular dynamics approaches reveal a promising multi-epitope vaccine against hantavirus

Shahid Ullah A. Tonks Carlos Eliel Maya-Ramírez Sabahat Abdullah Shahzad Khalil Tasnim Jahan Tonni Mohammed Hasan Abbas Ahmad

Oct 2026 · In Silico Pharmacology · Vol 14 · 0 citations · 76 references

Medicine

TL;DR

The proposed MEVC demonstrated favorable predicted immunogenicity, favorable structural characteristics, broad population coverage, and favorable expression characteristics, which support experimental validation and development of a preventive strategy against Hantavirus infection.

DOI PubMed Semantic Scholar

Read PDF

Similar papers

Open access Oct 2026

Designing a multi-epitope vaccine against La Crosse virus using immunoinformatics approach

Overall, the proposed vaccine candidate V1 demonstrates strong immunogenic potential and structural stability, warranting further experimental validation for potential clinical application.

Md. Shamiron Hasnat, A. Saim, Mst. Bithi Akter Sarmin et al. · PLoS ONE · 0 citations

Open access Sep 2026

In silico design of a multi-epitope mRNA vaccine candidate against rift valley fever virus using integrative immunoinformatics approaches

Rift Valley fever virus (RVFV) is a major zoonotic pathogen causing significant outbreaks in humans and livestock, with no licensed effective vaccines currently available and reverse vaccinology and immunoinformatics approaches were employed to design three multi-epitope mRNA vaccine candidates against RVFV.

E. K. Oladipo, James Akinwumi Ogunniran, Biobele Winner Sokari et al. · Discover Immunity · 0 citations

Open access Sep 2026

From Epitope Discovery to Immune Simulation: An Integrated Computational Strategy for Multi-Epitope Vaccine Design Against Human Mastadenovirus

Human Adenovirus (ADV), a member of the Adenoviridae family, is Double-Stranded DNA (DSDNA) virus associated with gastroenteritis, conjunctivitis, and severe respiratory infection and illnesses in infants and immunocompromised individuals. Despite its widespread prevalence in food and water sources, no specific and eff...

Arshad Iqbal · Global Journal of Pharmacy &... · 0 citations

Open access Oct 2026

An Immunoinformatics-Based Multi-Epitope Vaccine Targeting Multiple Stages of Tuberculosis Pathogenesis

Tuberculosis (TB), caused by Mycobacterium tuberculosis (M. tuberculosis), remains one of the leading causes of mortality from infectious diseases worldwide, underscoring the urgent need for more effective vaccine strategies. Advances in immunoinformatics have enabled rational, cost-effective vaccine design through sys...

Sema Karabudak, S. Altunok, Emre Can Buluz · Fabad journal of pharmaceuti... · 0 citations

Open access Sep 2026

Immunoinformatics-guided design and in silico evaluation of BAFF- and APRIL-adjuvanted multi-epitope vaccine candidates against human metapneumovirus

An immunoinformatics-guided reverse vaccinology approach to design novel BAFF- and APRIL-adjuvanted multi-epitope vaccine candidates against HMPV identified BAFF- and APRIL-containing multi-epitope constructs with favorable predicted antigenic, physicochemical, structural, and immunological characteristics that warrant...

Reham M. Alahmadi, M. Awadalla, Halah Z. Al-Rawi et al. · Frontiers in Virology · 0 citations

Open access Oct 2026

An immunoinformatics-driven multiepitope subunit vaccine targeting Oropouche virus: Molecular docking, immune and dynamics simulation approaches

The Oropouche virus (OROV) is an emerging zoonotic orthobunyavirus responsible for recurring outbreaks of febrile illness and neurological disorders in South and Central America. Despite its growing public health issues, no FDA-approved vaccines or antiviral therapies currently exist. To address this gap, a multiepitop...

Jwel Sharma, Ahmad Abdullah Mahdeen · PLoS ONE · 0 citations